ELVN ENLIVEN THERAPEUTICS INC More: the full row for ENLIVEN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 535,092 shares; 2025Q1: 535,092 shares; 2025Q2: 509,987 shares; 2025Q3: 783,411 shares; 2025Q4: not reported; 2026Q1: 623,839 shares; 2026Q2: 954,360 shares; 2026Q3: 958,700 shares 958,700 $43.9M 5.84% +4,340 Timeline GH GUARDANT HEALTH INC More: the full row for GUARDANT HEALTH INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 315,737 shares; 2025Q2: 302,307 shares; 2025Q3: not reported; 2025Q4: 271,685 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 219,304 shares 219,304 $39.1M 5.19% new Timeline ABVX ABIVAX SA More: the full row for ABIVAX SA Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 291,820 shares; 2025Q4: 381,233 shares; 2026Q1: 465,869 shares; 2026Q2: 489,889 shares; 2026Q3: 384,592 shares 384,592 $38.1M 5.06% -105,297 Timeline ROIV ROIVANT SCIENCES LTD More: the full row for ROIVANT SCIENCES LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 959,703 shares; 2025Q4: 1,186,817 shares; 2026Q1: 1,190,118 shares; 2026Q2: 1,331,066 shares; 2026Q3: 985,583 shares 985,583 $36M 4.79% -345,483 Timeline UTHR UNITED THERAPEUTICS CORP DEL More: the full row for UNITED THERAPEUTICS CORP DEL Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 85,318 shares; 2025Q4: 63,580 shares; 2026Q1: 104,726 shares; 2026Q2: 84,932 shares; 2026Q3: 60,064 shares 60,064 $32.5M 4.32% -24,868 Timeline VRDN VIRIDIAN THERAPEUTICS INC More: the full row for VIRIDIAN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 690,528 shares; 2026Q1: 911,337 shares; 2026Q2: 1,670,000 shares; 2026Q3: 1,525,220 shares 1,525,220 $31.4M 4.17% -144,780 Timeline AXSM AXSOME THERAPEUTICS INC. More: the full row for AXSOME THERAPEUTICS INC. Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 192,146 shares; 2025Q1: 118,179 shares; 2025Q2: 144,400 shares; 2025Q3: 152,614 shares; 2025Q4: 206,921 shares; 2026Q1: 188,772 shares; 2026Q2: 218,415 shares; 2026Q3: 162,407 shares 162,407 $29.9M 3.98% -56,008 Timeline INSM INSMED INC More: the full row for INSMED INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 446,980 shares; 2025Q1: 401,629 shares; 2025Q2: 372,672 shares; 2025Q3: 319,773 shares; 2025Q4: 264,293 shares; 2026Q1: 248,475 shares; 2026Q2: 263,851 shares; 2026Q3: 245,726 shares 245,726 $28M 3.72% -18,125 Timeline CELC CELCUITY INC More: the full row for CELCUITY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 210,578 shares; 2026Q2: 329,101 shares; 2026Q3: 329,101 shares 329,101 $26.2M 3.48% 0 Timeline CRL CHARLES RIV LABS INTL INC More: the full row for CHARLES RIV LABS INTL INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 86,801 shares 86,801 $25.6M 3.4% new Timeline CYTK CYTOKINETICS INC More: the full row for CYTOKINETICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 254,795 shares; 2025Q4: 325,668 shares; 2026Q1: 283,700 shares; 2026Q2: 527,412 shares; 2026Q3: 357,945 shares 357,945 $23.6M 3.13% -169,467 Timeline BBIO BRIDGEBIO PHARMA INC More: the full row for BRIDGEBIO PHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 452,290 shares; 2025Q1: 656,699 shares; 2025Q2: 551,684 shares; 2025Q3: 589,729 shares; 2025Q4: 595,473 shares; 2026Q1: 695,718 shares; 2026Q2: 633,364 shares; 2026Q3: 354,371 shares 354,371 $23.3M 3.1% -278,993 Timeline PRAX PRAXIS PRECISION MEDICINES I More: the full row for PRAXIS PRECISION MEDICINES I Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 45,536 shares; 2025Q1: 71,775 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 35,749 shares; 2026Q1: 42,441 shares; 2026Q2: 83,528 shares; 2026Q3: 78,806 shares 78,806 $23M 3.05% -4,722 Timeline ORIC ORIC PHARMACEUTICALS INC More: the full row for ORIC PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,451,037 shares; 2025Q1: 2,027,430 shares; 2025Q2: 2,009,923 shares; 2025Q3: 2,159,474 shares; 2025Q4: 2,010,307 shares; 2026Q1: 2,017,284 shares; 2026Q2: 2,017,284 shares; 2026Q3: 1,574,334 shares 1,574,334 $21.2M 2.82% -442,950 Timeline RGEN REPLIGEN CORP More: the full row for REPLIGEN CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 108,436 shares 108,436 $20.8M 2.77% new Timeline TNGX TANGO THERAPEUTICS INC More: the full row for TANGO THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 766,860 shares 766,860 $19.1M 2.54% new Timeline RVMD REVOLUTION MEDICINES INC More: the full row for REVOLUTION MEDICINES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 403,915 shares; 2025Q1: 340,109 shares; 2025Q2: 415,591 shares; 2025Q3: 643,050 shares; 2025Q4: 638,385 shares; 2026Q1: 468,376 shares; 2026Q2: 415,307 shares; 2026Q3: 92,316 shares 92,316 $18.9M 2.52% -322,991 Timeline INBX INHIBRX BIOSCIENCES INC More: the full row for INHIBRX BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 164,783 shares; 2026Q3: 171,512 shares 171,512 $17.2M 2.28% +6,729 Timeline NAMS NEWAMSTERDAM PHARMA COMPANY More: the full row for NEWAMSTERDAM PHARMA COMPANY Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 521,097 shares; 2025Q3: 716,971 shares; 2025Q4: 893,473 shares; 2026Q1: 558,336 shares; 2026Q2: 582,497 shares; 2026Q3: 702,396 shares 702,396 $17.1M 2.27% +119,899 Timeline MANE VERADERMICS INC More: the full row for VERADERMICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 136,718 shares 136,718 $16.6M 2.2% new Timeline COGT COGENT BIOSCIENCES INC More: the full row for COGENT BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 824,283 shares; 2026Q1: 947,339 shares; 2026Q2: 602,281 shares; 2026Q3: 514,976 shares 514,976 $16.5M 2.19% -87,305 Timeline DNTH DIANTHUS THERAPEUTICS INC More: the full row for DIANTHUS THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 220,921 shares; 2026Q2: 285,771 shares; 2026Q3: 178,573 shares 178,573 $15.7M 2.09% -107,198 Timeline PVLA PALVELLA THERAPEUTICS INC NE More: the full row for PALVELLA THERAPEUTICS INC NE Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 148,093 shares; 2026Q2: 156,450 shares; 2026Q3: 109,871 shares 109,871 $15.2M 2.01% -46,579 Timeline RYTM RHYTHM PHARMACEUTICALS INC More: the full row for RHYTHM PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 146,303 shares; 2026Q1: not reported; 2026Q2: 154,018 shares; 2026Q3: 157,603 shares 157,603 $15M 1.99% +3,585 Timeline RCUS ARCUS BIOSCIENCES INC More: the full row for ARCUS BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 565,142 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 577,693 shares 577,693 $14.9M 1.98% new Timeline ARWR ARROWHEAD PHARMACEUTICALS IN More: the full row for ARROWHEAD PHARMACEUTICALS IN Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 222,649 shares 222,649 $14.6M 1.94% new Timeline IRON DISC MEDICINE INC More: the full row for DISC MEDICINE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 299,464 shares; 2025Q3: 397,693 shares; 2025Q4: 153,206 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 220,666 shares 220,666 $14.4M 1.92% new Timeline ERAS ERASCA INC More: the full row for ERASCA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 867,639 shares; 2026Q2: 1,221,721 shares; 2026Q3: 913,452 shares 913,452 $13.4M 1.78% -308,269 Timeline GRAL GRAIL INC More: the full row for GRAIL INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 93,727 shares 93,727 $13.1M 1.74% new Timeline KYMR KYMERA THERAPEUTICS INC More: the full row for KYMERA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 277,726 shares; 2025Q4: 206,445 shares; 2026Q1: 254,672 shares; 2026Q2: 102,533 shares; 2026Q3: 113,299 shares 113,299 $12.7M 1.68% +10,766 Timeline ASND ASCENDIS PHARMA A/S More: the full row for ASCENDIS PHARMA A/S Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 104,877 shares; 2026Q3: 54,594 shares 54,594 $12.4M 1.65% -50,283 Timeline QURE UNIQURE NV More: the full row for UNIQURE NV Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 321,655 shares; 2026Q1: 615,489 shares; 2026Q2: 608,925 shares; 2026Q3: 465,474 shares 465,474 $11.2M 1.49% -143,451 Timeline XENE XENON PHARMACEUTICALS INC More: the full row for XENON PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 684,986 shares; 2025Q1: 683,451 shares; 2025Q2: 660,617 shares; 2025Q3: 799,743 shares; 2025Q4: 799,743 shares; 2026Q1: 786,844 shares; 2026Q2: 600,200 shares; 2026Q3: 297,060 shares 297,060 $11M 1.47% -303,140 Timeline SYRE SPYRE THERAPEUTICS INC More: the full row for SPYRE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 102,541 shares 102,541 $9.13M 1.21% new Timeline SMMT SUMMIT THERAPEUTICS INC More: the full row for SUMMIT THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 501,724 shares 501,724 $8.48M 1.13% new Timeline DFTX DEFINIUM THERAPEUTICS INC More: the full row for DEFINIUM THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 216,531 shares 216,531 $8.24M 1.09% new Timeline PCVX VAXCYTE INC More: the full row for VAXCYTE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 276,905 shares; 2025Q1: 276,905 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 443,836 shares; 2026Q3: 137,534 shares 137,534 $7.83M 1.04% -306,302 Timeline HNGE HINGE HEALTH INC More: the full row for HINGE HEALTH INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 75,448 shares 75,448 $7.34M 0.97% new Timeline